EPI64 Antibodies

Santa Cruz Biotechnology features a diverse variety of EPI64 Antibodies for advanced research in cellular signaling and protein interactions. EPI64 Antibodies are compatible with multiple techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EPI64, or Epithelial Protein 64, plays a crucial role in regulating cellular processes such as apoptosis and cell proliferation. The involvement of EPI64 in the modulation of signaling pathways makes it significant for understanding various diseases, including cancer and neurodegenerative disorders. Research focused on EPI64 can reveal potential therapeutic targets and treatment strategies. Scientists worldwide utilize EPI64 monoclonal antibodies to advance their understanding of cellular mechanisms. Investigating EPI64 functions helps unlock new possibilities in disease treatment and prevention. Santa Cruz Biotechnology monoclonal antibodies enable researchers to make meaningful contributions to scientific knowledge and therapeutic development.